e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Lung cancer biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled aldehydes as markers of disease in lung cancer patients
E. Straker, C. Loesecken, P. Fuchs, W. Miekisch, J. Schubert (Rostock, Germany)
Source:
Annual Congress 2009 - Lung cancer biology
Session:
Lung cancer biology
Session type:
E-Communication Session
Number:
291
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Straker, C. Loesecken, P. Fuchs, W. Miekisch, J. Schubert (Rostock, Germany). Exhaled aldehydes as markers of disease in lung cancer patients. Eur Respir J 2009; 34: Suppl. 53, 291
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Protein markers in the exhaled breath condensate of lung carcinoma patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Exhaled volatile organic compounds as biomarkers for respiratory diseases
Source: Eur Respir Monogr 2010; 49: 130-139
Year: 2010
Exhaled MMP-9 in lung cancer
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012
Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients?
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011
Dermcidin identification from exhaled air for lung cancer diagnosis
Source: Eur Respir J 2010; 35: 1182-1185
Year: 2010
Tumor size and inflammatory cytokines in exhaled breath condensate in patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
HPV in exhaled breath condensate of lung cancer patients
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002
Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Exhaled biomarkers in lung cancer
Source: Eur Respir J 2009; 34: 261-275
Year: 2009
Exhaled aldehydes as markers of disease in critically ill patients
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009
Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study.
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Comparison of exhaled biomarkers to other markers of airway diseases
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept